<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260713070174N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-12</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison of the Effectiveness of Mentalization-Based Therapy and Acceptance and Commitment Therapy in Adolescents with a History of Suicide Attempt</public_title>
      <acronym>MBT-ACT</acronym>
      <scientific_title>Comparison of the Effectiveness of Mentalization-Based Therapy (MBT) and Acceptance and Commitment Therapy (ACT) in Reducing Impulsivity and Suicidal Ideation and Enhancing Resilience and Cognitive Flexibility in Adolescents with a History of Suicide Attempt in Shiraz</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-09-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/91851</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Simple Randomization Method: Following the confirmation of eligibility criteria and the acquisition of informed consent, participants are randomly assigned—using a random number table or computer-generated random numbers—with equal probability to one of two groups: Mentalization-Based Treatment (MBT) or Acceptance and Commitment Therapy (ACT). The allocation process ensures that each participant has an equal chance of being assigned to either group. The control group receives no treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Suicide.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Intervention group: In this study, the first intervention group received Mentalization-Based Treatment (MBT) based on the protocol developed by Malberg (2021). The intervention was structured over 10 sessions with the aim of enhancing participants’ ability to understand their own and others’ thoughts, emotions, and behaviors. In the initial sessions, the fundamental concepts of mentalization, emotional awareness, difficulties related to mind-reading, impulsivity, and interpersonal sensitivity were introduced, enabling participants to gain greater insight into their internal states and those of others. During the middle sessions, skills related to emotion regulation, effective communication, mentalization practice, and the exploration of individual difficulties within a group context were taught. Furthermore, through clarification and a focus on participants’ emotional experiences, the therapist facilitated the development of interpersonal trust and relational understanding. In the final session, the therapeutic process was reviewed, and participants’ feelings regarding treatment termination and their achieved outcomes were explored. Intervention 2: Intervention group: In this study, the second intervention group received Acceptance and Commitment Therapy (ACT) based on Hayes’ (2004) protocol over eight sessions. The intervention was designed to enhance psychological flexibility, promote acceptance of internal experiences, and facilitate engagement in value-consistent behaviors. In the initial sessions, the therapeutic relationship, treatment contract, psychoeducation, exploration of personal experiences, the ineffectiveness of excessive control strategies, and the concept of creative hopelessness were addressed. During the middle sessions, cognitive defusion techniques, self-as-context, mindfulness practices, and changing individuals’ relationships with their thoughts and emotions were introduced and practiced. In the final sessions, participants explored personal values, developed commitment to purposeful actions, and established behavioral patterns aligned with their values, enabling them to respond more effectively to internal experiences and life challenges.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data relating to the study participants is confidential and will be used solely for statistical analysis.

When:
The data from this study will be accessible for a period of 6 months after the publication of the research results in the form of scholarly articles.

To whom:
The data will be accessible to the researchers, including Dr. Mohammad Ranjbar, Dr. Ali Mohammad Rezaei, and Dr. Akbar Rezaei Fard, and the published articles will be made available to them.

Conditions:
The statistical analysis output will be available.

Where to obtain:
Applicants can contact via email at mohammad.ranjbar271174@gmail.com or WhatsApp at 09174137101.

How to obtain:
After the completion of the research and publication of the extracted articles, it will be available for a maximum of 6 months.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Ranjbar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>First Floor, Ranjbar 3-Story Building, Alley 2, Sour Esrafil St., Atalasi, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7344115569</zip>
        <telephone>+98 71 3272 8290</telephone>
        <email>mohammad.ranjbar271174@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Ali Mohammad Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>End of Daneshgah Blvd., Daneshgah St., Arsanjan, Postal Code: 7376153161</address>
        <city>Arsanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۷۳۷۶۱۵۳۱۶۱</zip>
        <telephone>+98 71 4352 3908</telephone>
        <email>dr.rezaie@iau.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a history of at least one previous suicide attempt
Having sufficient psychological stability to participate in the study
Being literate and able to complete the study questionnaires
Not receiving similar psychotherapy during the study intervention period
Providing written informed consent from both the participant and their parent or legal guardian</inclusion_criteria>
      <agemin>13 years</agemin>
      <agemax>19 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Emergence of an immediate risk of suicide or severe intensification of suicidal thoughts.
Severe psychiatric disorders (such as active psychosis, or bipolar disorder in a manic or hypomanic phase)...
Suffering from acute physical illnesses or serious medical conditions that prevent regular attendance at therapy sessions.
Withdrawal of the participant or their parent/legal guardian from further participation, as well as the emergence of any new psychiatric or medical condition that renders continued participation in the study ethically or therapeutically inappropriate.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T14.91</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Suicide attempt</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Intervention group: In this study, the first intervention group received Mentalization-Based Treatment (MBT) based on the protocol developed by Malberg (2021). The intervention was structured over 10 sessions with the aim of enhancing participants’ ability to understand their own and others’ thoughts, emotions, and behaviors. In the initial sessions, the fundamental concepts of mentalization, emotional awareness, difficulties related to mind-reading, impulsivity, and interpersonal sensitivity were introduced, enabling participants to gain greater insight into their internal states and those of others. During the middle sessions, skills related to emotion regulation, effective communication, mentalization practice, and the exploration of individual difficulties within a group context were taught. Furthermore, through clarification and a focus on participants’ emotional experiences, the therapist facilitated the development of interpersonal trust and relational understanding. In the final session, the therapeutic process was reviewed, and participants’ feelings regarding treatment termination and their achieved outcomes were explored.</i_keyword>
      <i_keyword>Intervention group: In this study, the second intervention group received Acceptance and Commitment Therapy (ACT) based on Hayes’ (2004) protocol over eight sessions. The intervention was designed to enhance psychological flexibility, promote acceptance of internal experiences, and facilitate engagement in value-consistent behaviors. In the initial sessions, the therapeutic relationship, treatment contract, psychoeducation, exploration of personal experiences, the ineffectiveness of excessive control strategies, and the concept of creative hopelessness were addressed. During the middle sessions, cognitive defusion techniques, self-as-context, mindfulness practices, and changing individuals’ relationships with their thoughts and emotions were introduced and practiced. In the final sessions, participants explored personal values, developed commitment to purposeful actions, and established behavioral patterns aligned with their values, enabling them to respond more effectively to internal experiences and life challenges.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Impulsivity. Timepoint: before the intervention, after the intervention, and two months after the intervention endedIf you want, I can also give you a more formal academic version. Method of measurement: Barratt Impulsiveness Scale (Barratt et al., 1995).</prim_outcome>
      <prim_outcome>Suicidal Ideation. Timepoint: before the intervention, after the intervention, and two months after the intervention ended. Method of measurement: Beck Scale for Suicide Ideation (BSSI).</prim_outcome>
      <prim_outcome>Resilience. Timepoint: before the intervention, after the intervention, and two months after the intervention ended. Method of measurement: Connor-Davidson Resilience Scale (CD-RISC, 2003).</prim_outcome>
      <prim_outcome>Cognitive Flexibility. Timepoint: before the intervention, after the intervention, and two months after the intervention ended. Method of measurement: Cognitive Flexibility Inventory (CFI; Dennis &amp; Vander Wal, 2010).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University, Arsanjan Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-22</approval_date>
        <contact_name>Ethics Committee of Arsenjan Branch, Islamic Azad University</contact_name>
        <contact_address>Islamic Azad University, Arsanjan Branch, Daneshgah St., Arsanjan, Fars Province, Postal Code: 7376153161 ارسنجان Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
